查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1418350

生物製药辅料市场报告：2030 年趋势、预测与竞争分析

Biopharmaceuticals Excipients Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

生物製药辅料的趋势与预测

预计到 2030 年，全球生物製药辅料市场将达到 40 亿美元，2024 年至 2030 年复合年增长率为 5.6%。该市场的主要驱动力是越来越多地采用多功能辅料以及製药公司对非专利市场的日益关注。全球生物製药辅料市场的未来前景广阔，增溶剂/界面活性剂/乳化剂、多元醇和碳水化合物市场充满机会。

生物製药辅料市场洞察

Lucintel 预测，由于对蛋白质疗法的需求增加，碳水化合物在预测期内仍将是最大的细分市场。

由于对生物製药製造的高需求，北美在预测期内仍将是最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到2030年，全球生物製药辅料市场预计将达到40亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球生物製药辅料市场预计将以5.6%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是多功能辅料的日益采用以及製药公司对非专利市场的日益关注。

Q4.市场的主要细分市场是什么？

A4. 生物製药辅料市场前景广阔，增溶剂/界面活性剂/乳化剂、多元醇和碳水化合物市场充满机会。

Q5.市场上主要企业有哪些？

A5. 生物製药辅料的主要企业如下。

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于对蛋白质治疗药物的需求增加，碳水化合物在预测期内仍将是最大的细分市场。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 在预测期内，北美将继续成为最大的地区，因为对生物製药製造的需求很高。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球生物製药辅料市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球生物製药辅料市场趋势（2018-2023）与预测（2024-2030）
  • 全球生物製药辅料市场（按产品）
    • 增溶剂和界面活性剂/乳化剂
    • 多元醇
    • 碳水化合物

第四章 2018-2030年区域市场趋势及预测分析

  • 全球生物製药辅料市场区域分布
  • 北美生物製药辅料市场
  • 欧洲生物製药辅料市场
  • 亚太生物製药辅料市场
  • 其他地区生物药辅料市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球生物製药辅料市场成长机会（按产品）
    • 全球生物製药辅料市场成长机会（按地区）
  • 全球生物製药辅料市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球生物製药辅料市场的产能
    • 全球生物製药辅料市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant
简介目录

Biopharmaceuticals Exicipents Trends and Forecast

The future of the global biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets. The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

A more than 150-page report is developed to help in your business decisions.

Biopharmaceuticals Exicipents by Segment

The study includes a forecast for the global biopharmaceuticals exicipents by products and region.

Biopharmaceuticals Exicipents Market by Products [Shipment Analysis by Value from 2018 to 2030]:

  • Solubilizes & Surfactants/Emulsifiers
  • Polyols
  • Carbohydrates

Biopharmaceuticals Exicipents Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biopharmaceuticals Exicipents Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biopharmaceuticals exicipents companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopharmaceuticals exicipents companies profiled in this report include-

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant

Biopharmaceuticals Exicipents Market Insights

Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Features of the Global Biopharmaceuticals Exicipents Market

Market Size Estimates: Biopharmaceuticals exicipents market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biopharmaceuticals exicipents market size by products, region, and region in terms of value ($B).

Regional Analysis: Biopharmaceuticals exicipents market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products and regions for the biopharmaceuticals exicipents market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopharmaceuticals exicipents market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biopharmaceuticals exicipents market size?

Answer: The global biopharmaceuticals exicipents market is expected to reach an estimated $4 billion by 2030.

Q2. What is the growth forecast for biopharmaceuticals exicipents market?

Answer: The global biopharmaceuticals exicipents market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biopharmaceuticals exicipents market?

Answer: The major drivers for this market are increasing adoption of multifunctional excipients and growing focus of pharmaceutical players on the generic market.

Q4. What are the major segments for biopharmaceuticals exicipents market?

Answer: The future of the biopharmaceuticals exicipents market looks promising with opportunities in the solubilizes & surfactants/emulsifiers, polyols, and carbohydrates markets.

Q5. Who are the key biopharmaceuticals exicipents market companies?

Answer: Some of the key biopharmaceuticals exicipents companies are as follows.

  • Merck
  • Colorcon
  • BASF
  • Associated British Foods
  • Signet Excipients
  • Sigachi Industries
  • Spectrum Chemical Manufacturing
  • Roquette Freres
  • IMCD
  • Clariant

Q6. Which biopharmaceuticals exicipents market segment will be the largest in future?

Answer: Lucintel forecasts that carbohydrates will remain the largest segment over the forecast period due to increasing demand for protein therapeutics.

Q7. In biopharmaceuticals exicipents market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to substantial need for biopharmaceutical production.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biopharmaceuticals exicipents market by products (solubilizes & surfactants/emulsifiers, polyols, and carbohydrates) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biopharmaceuticals Exicipents Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biopharmaceuticals Exicipents Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biopharmaceuticals Exicipents Market by Products
    • 3.3.1: Solubilizes & Surfactants/Emulsifiers
    • 3.3.2: Polyols
    • 3.3.3: Carbohydrates

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biopharmaceuticals Exicipents Market by Region
  • 4.2: North American Biopharmaceuticals Exicipents Market
  • 4.3: European Biopharmaceuticals Exicipents Market
    • 4.3.1: European Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
  • 4.4: APAC Biopharmaceuticals Exicipents Market
    • 4.4.1: APAC Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates
  • 4.5: ROW Biopharmaceuticals Exicipents Market
    • 4.5.1: ROW Biopharmaceuticals Exicipents Market by Products: Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Products
    • 6.1.2: Growth Opportunities for the Global Biopharmaceuticals Exicipents Market by Region
  • 6.2: Emerging Trends in the Global Biopharmaceuticals Exicipents Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biopharmaceuticals Exicipents Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceuticals Exicipents Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: Colorcon
  • 7.3: BASF
  • 7.4: Associated British Foods
  • 7.5: Signet Excipients
  • 7.6: Sigachi Industries
  • 7.7: Spectrum Chemical Manufacturing
  • 7.8: Roquette Freres
  • 7.9: IMCD
  • 7.10: Clariant